Else Nutrition Announces Up-Listing to the Toronto Stock Exchange
January 24 2022 - 7:00AM
Else Nutrition Holdings Inc.
(TSXV: BABY) (OTCQX: BABYF)
(FSE: 0YL) (“
Else” or, the
“
Company”) is pleased to announce that it has
received final approval for the listing of its common shares and
warrants on the Toronto Stock Exchange (the
“
TSX”).
The Company’s common shares and warrants will
commence trading on the TSX effective as of market open on Tuesday,
January 25, 2022, under the current trading symbols of “BABY”,
“BABY.WT” and “BABY.WT.A”. In connection with the TSX listing, the
Company’s common shares and warrants will be concurrently delisted
from the TSX Venture Exchange.
The TSX is the premier stock exchange for
Canadian and international companies, offering enhanced visibility,
liquidity, and access to capital. ELSE believes that a TSX listing
is a logical next step in the Company’s progression which should
facilitate access to a broader range of investors.
“Listing on the TSX is a confirmation of our
progress and marks another milestone on our journey, as we take
significant strides in preparing ELSE for global growth,” said
Hamutal Yitzhak, ELSE co-founder & CEO. “This up-listing will
serve to increase the exposure of our story and business potential
to additional investors in the capital markets community and will
further support growth of our investor base.”
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food
and nutrition company focused on developing innovative, clean and
plant-based food and nutrition products for infants, toddlers,
children, and adults. Its revolutionary, plant-based, non-soy,
formula is a clean-ingredient alternative to dairy-based formula.
Else Nutrition (formerly INDI) won the “2017 Best Health and Diet
Solutions” award at the Global Food Innovation Summit in Milan.
Else Plant-Based Complete Nutrition for Toddlers was recently
ranked as the #1 Top seller in the baby and toddler formula
category on Amazon. The holding company, Else Nutrition Holdings
Inc., is a publicly traded company, listed as TSX Venture Exchange
under the trading symbol BABY and is quoted on the US OTC Markets
QX board under the trading symbol BABYF and on the Frankfurt
Exchange under the symbol 0YL. Else’s Executives include leaders
hailing from leading infant nutrition companies. Many of Else
advisory board members had past executive roles in companies such
as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant
nutrition Societies, and some of them currently serve in different
roles in leading medical centers and academic institutes such as
Boston Children’s Hospital, Pediatrics at Harvard Medical School,
USA, Tel Aviv University, Schneider Children’s Medical Center of
Israel, Rambam Medical Center and Technion, Israel and University
Hospital Brussels, Belgium.
For more information,
visit: elsenutrition.com or @elsenutrition on Facebook
and Instagram.
Media ContactErin
JundefBrilliant PRerinj@brilliantpr.com
For more information,
contact:
Mrs. Hamutal Yitzhak, CEO, Co-Founder &
DirectorELSE Nutrition Holdings Inc.E: hamutaly@elsenutrition.comP:
+972(0)3-6445095
Mr. Sokhie Puar, Director of Else NutritionE:
sokhiep@elsenutrition.comP: 604-603-7787
US Investor Relations
Contact:
Lytham Partners, LLCMr. Ben ShamsianNew York |
PhoenixE: shamsian@lythampartners.comP: 646-829-9701
TSX Venture Exchange
Neither the TSX Venture Exchange nor its
regulation services provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Caution Regarding Forward-Looking
Statements
This press release contains statements that may
constitute “forward-looking statements” within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as “will”, “expect” or similar
expressions. Forward-looking statements in this press release
include statements with respect to the anticipated dates for filing
the Company’s financial disclosure documents. Such
forward-looking statements reflect current estimates, beliefs and
assumptions, which are based on management’s perception of current
conditions and expected future developments, as well as other
factors management believes are appropriate in the circumstances.
No assurance can be given that the foregoing will prove to be
correct. Forward-looking statements made in this press release
assume, among others, the expectation that listing on the FSE will
create additional liquidity and attract additional investors in the
European market. Actual results may differ from the estimates,
beliefs and assumptions expressed or implied in the forward-looking
statements. Readers are cautioned not to place undue reliance
on any forward-looking statements, which reflect management’s
expectations only as of the date of this press release. The Company
disclaims any obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as required by law.
Else Nutrition (TSXV:BABY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Else Nutrition (TSXV:BABY)
Historical Stock Chart
From Oct 2023 to Oct 2024